Research progress on non-protein-targeted drugs for cancer therapy.
J Exp Clin Cancer Res
; 42(1): 62, 2023 Mar 14.
Article
in English
| MEDLINE | ID: covidwho-2288699
ABSTRACT
Non-protein target drugs, especially RNA-based gene therapies for treating hereditary diseases, have been recognized worldwide. As cancer is an insurmountable challenge, no miracle drug is currently available. With the advancements in the field of biopharmaceuticals, research on cancer therapy has gradually focused on non-protein target-targeted drugs, especially RNA therapeutics, including oligonucleotide drugs and mRNA vaccines. This review mainly summarizes the clinical research progress in RNA therapeutics and highlights that appropriate target selection and optimized delivery vehicles are key factors in increasing the effectiveness of cancer treatment in vivo.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Neoplasms
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Exp Clin Cancer Res
Year:
2023
Document Type:
Article
Affiliation country:
S13046-023-02635-y
Similar
MEDLINE
...
LILACS
LIS